PP
Prangyan Paramita Mishra
About Prangyan Paramita Mishra
Data last updated:
Prangyan Paramita Mishra has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Carcinova Private Limited and Uncan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Carcinova Private Limited at ₹37.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2017 | 2017 | ₹37.02 Cr (FY 2025) | Active | |
| Director | 12 Jun 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prangyan Paramita Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prangyan Paramita Mishra
Prangyan Paramita Mishra has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Carcinova Private Limited and Uncan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Carcinova Private Limited at ₹37.02 Cr (FY 2025).
Prangyan Paramita Mishra is associated with 2 companies as Director, including Carcinova Private Limited (₹37.02 Cr), Uncan Pharmaceuticals Private Limited.
Prangyan Paramita Mishra has expertise in General Business.
Prangyan Paramita Mishra has 9 years in corporate governance.
By reported revenue, the largest current company of Prangyan Paramita Mishra is Carcinova Private Limited, with revenue of ₹37.02 Cr (FY 2025).
Prangyan Paramita Mishra currently holds positions at 2 companies: Carcinova Private Limited (₹37.02 Cr), Uncan Pharmaceuticals Private Limited.